Management of Stage 1 Esophageal Cancer

Surgical Clinics of North America

Volumn 92, Issue 5, 2012, Pages 1155-1167

  Hermansson, Michael ^a   DeMeester, Steven R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Endoscopic resection; Esophageal cancer; Radiofrequency ablation; Stage 1; Vagus sparing esophagectomy

Indexed keywords

PANCREAS POLYPEPTIDE;

BARRETT ESOPHAGUS; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; DISTANT METASTASIS; DYSPHAGIA; DYSPLASIA; EARLY CANCER; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HERNIA; HIGHLY SELECTIVE VAGOTOMY; HUMAN; INTESTINE METAPLASIA; JEJUNOSTOMY; JEJUNOSTOMY TUBE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NASOGASTRIC TUBE; NEEDLE BIOPSY; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT OUTCOME; TUBE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; NEOPLASM STAGING;

EID: 84866860116     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.07.014     Document Type: Review

References (40)

1. Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 15(127):2918-2927.
2. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265:1287-1289.
3. Kubo A., Corley D.A. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004, 99:582-588.
4. Pohl H., Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97:142-146.
5. Devesa S.S., Blot W.J., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83:2049-2053.
6. Bollschweiler E., Wolfgarten E., Gutschow C., et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001, 92:549-555.
7. Kubo A., Corley D.A. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002, 95:2096-2102.
8. Chen X., Yang C.S. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001, 22:1119-1129.
9. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999, 230:433-440.
10. Bolton W.D., Hofstetter W.L., Francis A.M., et al. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2009, 138:831-836.
11. Wang B.Y., Goan Y.G., Hsu P.K., et al. Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg 2011, 91:887-893.
12. Leers J.M., DeMeester S.R., Oezcelik A., et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg 2011, 253:271-278.
13. Endoscopic Classification Review Group Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005, 37:570-578.
14. Puli S.R., Batapati K.R., Bechtold M.L., et al. Endoscopic ultrasound: it's accuracy in evaluating mediastinal lymphadenopathy? A meta-analysis and systematic review. World J Gastroenterol 2008, 14:3028-3037.
15. Buttar N., Wang K.K., Lutzke L.S., et al. Combined endoscopic mucosal resection (EMR) and photodynamic therapy (PDT) for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001, 54:682-688.
16. Heidemann J., Schilling M.K., Schmassmann A., et al. Accuracy of endoscopic ultrasonography in preoperative staging of esophageal carcinoma. Dig Surg 2000, 17:219-224.
17. Menzel J., Hoepffner N., Nottberg H., et al. Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Endoscopy 1999, 31:291-297.
18. Hunerbein M., Ulmer C., Handke T., et al. Endosonography of upper gastrointestinal tract cancer on demand using miniprobes or endoscopic ultrasound. Surg Endosc 2003, 17:615-619.
19. Maish M.S., DeMeester S.R. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004, 78:1777-1782.
20. Tada M., Inoue H., Yabata E., et al. Colonic mucosal resection using a transparent cap-fitted endoscope. Gastrointest Endosc 1996, 44:63-65.
21. Little S.G., Rice T.W., Byble B., et al. Is FDG-PET indicated for superficial esophageal cancer?. Eur J Cardiothorac Surg 2007, 31:791-796.
22. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005, 62:488-498.
23. Gray N.A., Odze R.D., Spechler S.J. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol 2011, 106:1899-1908.
24. Krishnadath K.K., Wang K.K., Taniquchi K., et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000, 119:624-630.
25. Overholt B.F., Panjehpour M., Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003, 58:183-188.
26. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009, 360:2277-2288.
27. Bergman J.J., Zhang Y.M., He S., et al. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc 2011, 74:1181-1190.
28. van Vilsteren F.G., Alvarez Herrero L., Pouw R.E., et al. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma. Endoscopy 2011, 43:282-290.
29. Orringer M.B., Marshall B., Chang A.C., et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 2007, 246:363-372.
30. Banki F., Mason R.J., DeMeester S.R., et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002, 236:324-335.
31. Peyre C.G., DeMeester T.R. Vagal-sparing esophagectomy. Adv Surg 2008, 42:109-116.
32. Akiyama H., Tsurumaru M., Kawamura T., et al. Esophageal stripping with preservation of the vagus nerve. Int Surg 1982, 67:125-128.
33. DeMeester S.R. Colon interposition following esophagectomy. Dis Esophagus 2001, 14:169-172.
34. Zehetner J., DeMeester S.R., Hagen J.A., et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg 2011, 141:39-47.
35. Pech O., Bollschweiler E., Manner H., et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg 2011, 254:67-72.
36. Pacifico R.J., Wang K.K., Wongkeesong L.M., et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 2003, 1:252-257.
37. Rice T.W., Mason D.P., Murthy S.C., et al. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg 2007, 133:317-324.
38. Grotenhuis B.A., van Heijl M., Zehetner J., et al. Surgical management of submucosal esophageal cancer: extended or regional lymphadenectomy?. Ann Surg 2010, 252:823-830.
39. Omloo J.M., Lagarde S.M., Hulscher J.B., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007, 246:992-1000.
40. Johansson J., DeMeester T.R., Hagen J.A., et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 2004, 139:627-631.